BEIJING, Aug. 28, 2025 -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that its board of directors (the "Board") has received a revised preliminary non-binding proposal letter (the "Revised Proposal Letter"), dated August 26, 2025, from a consortium (the "Consortium") comprised of Oceanpine Investme
SAN JOSE, Calif., Aug. 28, 2025 -- Reallusion officially releases Character Creator 5 (CC5), a major upgrade that brings the character creation ecosystem into the HD era. Its powerful subdivision workflow bridges game-ready 3D characters with film-quality rendering. This release includes all-new HD Morphs, anatomically accurate human bases, the next-gen ActorMIXER PRO plugin, and an advanced HD facial animation system. Step into the future of expressive, lifelike, production-ready digital humans. With CC5, existing users can upgrade their legacy characters to HD quality, unlock
[ 메디채널 김갑성 기자 ] 선양, 중국 2025년 8월 28일 -- 의료 영상 솔루션 및 서비스 분야의 글로벌 선도기업 뉴소프트 메디컬 시스템즈(Neusoft Medical Systems)가 27일 자사의 NeuViz P10 광자 계수 CT(photon-counting CT)가 중국 국가약품감독관리국(National Medical Products Administration•NMPA)으로부터 시판 허가를 받았다고 밝혔다. 중국에서 광자 계수 CT가 승인된 건 NeuViz P10가 처음이다. NeuViz P10는 전 세계 최초로 8cm 검출기를 탑재한 와이드 바디 시스템이다. 광자 계수 CT는 차세대 영상 기술의 혁신으로 간주된다. X선을 먼저 빛으로 변환한 후 디지털 영상을 생성하는 기존 CT 스캐너와 달리 NeuViz P10은 카드뮴•아연•텔루라이드(CZT) 검출기를 사용해 각 X선 광자를 직접 포착해 디지털 신호로 변환한다. 이러한 직접적인 접근 방식은 훨씬 더 선명한 영상을 제공하고 환자의 방사선 노출을 줄이면서 서로 다른 종류의 조직을 구별하는 능력을 향상시킨다. 이러한 발전 덕분에 환자 심장의 미세 혈관을
Operating Expenses Reduced by 16% To Date, Full Impact Anticipated in H2 2025 and Beyond Announcing Shareholder Return Program of No Less Than HKD600 Million Embracing the New AI Era: AI Content Factory Empowering the Entire Company HONG KONG, Aug. 28, 2025 -- NetDragon Websoft Holdings Limited ("NetDragon" or the "Company"; Hong Kong Stock Code: 777), a global leader in building internet communities, today announced its financial results for the first half of 2025. NetDragon's management team will hold a conference call and webcast at 10:00am
This round of capital is the largest raised among deep tech and energy companies since CFS' $1.8 billion Series B round in 2021. The almost $3 billion that CFS has raised to date is about one-third of the total capital invested in private fusion companies worldwide, solidifying its leadership of the fusion industry. In recognition of the new category of energy technology that the company is creating, CFS expanded its global footprint by adding international investors from a widening range of sectors — from long-established fundamental investors, technology and industrial compani
BEIJING, Aug. 28, 2025 -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced the launch of two forward-looking initiatives intended to fully integrate China's strengths in smart, connected new energy vehicles (NEVs) and collaborate with partners to navigate the global landscape of next-generation data-driven automotive innovation with AI-Driven Intelligent Insurance Tool and Fintech Solution for Automakers Abroad. In the first half of 2025, the number of Cheche's NEV insurance policies ex
Outperforming the Market HONG KONG, Aug. 28, 2025 -- KLN Logistics Group Limited ('KLN' or together with its subsidiaries, the 'Group'; Stock Code 0636.HK) today announced the Group's interim results for the six months ended 30 June 2025. Group's Financial Highlights Revenue grew by 7% year-on-year to HK$27,211 million (2024 1H*: HK$25,432 million) Core operating profit increased by 12% to HK$1,348 million (2024 1H*: HK$1,200 million) Core net profit also increased by 12% year-on-year to HK$681 million (2024 1H*: HK$606 million) Excluding the one-off gain on dis
[ 메디채널 김갑성 기자 ] Committed to net-zero across the value chain by 2050 Aligned with 1.5°C mitigation pathways, the most ambitious SBTi designation Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, Aug. 28, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced its near-term and net-zero greenhouse gas (GHG) emissions reduction targets have been approved by the Science Based Targets initiative (SBTi). WuXi Biologics is one of the first companies in the industry t
TAIPEI, Aug. 28, 2025 -- Travel is more than a brief escape from everyday life—it is a journey to rediscover emotions and connections. Guided by the philosophy of "to serve as we would like to be served," Silks Hotel Group extends world-class hospitality into meaningful cultural encounters. With 14 properties across Taiwan, the Group invites international travelers to begin their cultural discovery from the hotel itself, venturing into local traditions, landscapes, and human connections that make Taiwan unique. Silks Place Tainan: Tea Ritual × City Walks&
PASAY CITY, Philippines, Aug. 28, 2025 -- The SM Group is expanding its J.O.B.S. (Jobs Opportunities Building Skills) program by integrating skills training into its nationwide job fairs, further aligning its efforts with the country's push to address the skills gap and strengthen workforce readiness. Launched in partnership with the Technical Education and Skills Development Authority (TESDA), the initiative goes beyond job matching by providing access to TESDA-accredited training programs. This dual approach equips job seekers not only with employment opportunit